Wall Street's top analysts are betting on stocks like GoDaddy and Carvana to beat the market

"In our view, BLUE, with its gene and cell therapy platform, is one of the more potentially transformative and disruptive companies we've come across in some time" the analyst wrote.

Kasimov noted that the 2Q update was in-line with expectations following the company's recent ide-cel re-submission and compelling HGB-206 sickle cell disease data. All catalysts remain more or less on track says Kasimov with the Zynteglo EU launch in 2H20, and additional HGB-206 data and MAA filing for eli-cel by the end of the year.

"Overall, we remain encouraged by bluebird's progress across multiple clinical programs involving its potentially transformative gene therapy and CAR-T platforms " the analyst told investors on August 6. He now looks forward to clinical updates, a launch, and regulatory feedback over the course of 2020/2021 that could "serve to better inform the future potential of these products." Kasimov is ranked as the 12best healthcare analyst on TipRanks, and at #129 out of 6,858 tracked analysts across all sectors.

Monday , sp500, Dow Jones in max . Don't import data . Manipulators of market want this . Friday was the day .

Australia Australia Latest News, Australia Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wall Street Week Ahead: Bargain-hunters look to U.S. real estate stocks as S&P nears recordsAs the S&P 500 approaches fresh highs, some investors hope to pick up bargains in the battered U.S. real estate sector, where values of some major stocks have been cut in half this year. Canadian Reuter’s spews leftist propaganda to sway an American election. As someone who remembers what lead to 2007-2012 and is in Real Estate.
Source: Reuters - 🏆 2. / 97 Read more »